[
  {
    "objectID": "seminars.html",
    "href": "seminars.html",
    "title": "Seminarios 2024",
    "section": "",
    "text": "Incidencia de diabetes tipo 1 y su relación con la carga genética\n\n\nEn este seminario se presentó un panorama general de la diabetes tipo 1, haciendo énfasis en el componente genético de la enfermedad. Se mostraron resultados sobre incidencia de diabetes tipo 1 y los marcadores genéticos asociados en población Peruana\n\n\n\n\n\nDec 11, 2024\n\n\nDr. Segundo Seclen Santisteban\n\n\n\n\n\n\n\nEstudios de cohorte digitales\n\n\nEn este seminario se presentaron dos ejemplos diferentes de estudios de cohorte digitales y se enfocó la discusión en las oportunidades de establecer cohortes digitales en la LATAM\n\n\n\n\n\nNov 20, 2024\n\n\nDra. Gloria Aguayo y Omar Silverman\n\n\n\n\n\n\n\nUtilidad de la glicemia 1h-post carga en la caracterización de sujetos con Prediabetes\n\n\nEn este seminario se discute la utilidad de la prueba de glucemia 1hr postcarga para caracterizar a personas que viven con prediabetes, se abordan las pruebas diagnósticas de diabetes/prediabetes, la estratificaciíon del riesgo cardiometabólico y las estrategias de intervención en prediabetes\n\n\n\n\n\nOct 23, 2024\n\n\nDr. Juan Carlos Lizarzaburu Robles\n\n\n\n\n\n\n\nPresentaciones cortas de los miembros de la red\n\n\nEn este seminario tenemos seis invitados de diferentes países, incluyendo Chile, Argentina, Colombia y México. Se presentan temas sobre investigación en diabetes con un enfoque clínico y epidemiológico que se complementan con enfoques de investigación cualitativa y de ciencias básicas\n\n\n\n\n\nSep 18, 2024\n\n\nMiembros de la red\n\n\n\n\n\n\n\nEpidemiología de las complicaciones y mortalidad por diabetes mellitus tipo 2: datos de Latino-América\n\n\nEn este seminario se presentó el panorama epidemiológíco de las complicaciones de diabetes tipo 2, la mortalidad asociada y resultados de las medidas preventivas en personas con diabetes tipo 2 en América Latina\n\n\n\n\n\nAug 14, 2024\n\n\nDr. Antonio Bernabe-Ortiz\n\n\n\n\n\n\n\nDiabetes tipo 2 de inicio temprano en México\n\n\nEn este seminario se presentó una revisión exhaustiva de las características de la diabetes tipo 2 de inicio temprano y los resultados de diferentes estudios realizados en México\n\n\n\n\n\nJun 26, 2024\n\n\nDr. Carlos A. Aguilar Salinas\n\n\n\n\n\n\n\nEpidemiología de diabetes tipo 1/ Registro nacional de pacientes con diabetes tipo 1- RENACED-DT1\n\n\nEn este seminario se presentó el panorama actual de la diabetes tipo 1, y se presentó el registro nacional de pacientes con diabetes tipo 1 de México\n\n\n\n\n\nMay 22, 2024\n\n\nDra. Paula Diaz y Dra. Raquel Faradji\n\n\n\n\n\n\n\nGuías de Práctica Clínica en Diabetes\n\n\nLas Guías de Práctica Clínica (GPC) constituyen una herramienta útil para ayudar al personal de salud y a los pacientes en el proceso de la toma de decisiones sobre cuáles son las intervenciones más adecuadas para resolver un problema de salud en circunstancias sanitarias específicas. Este seminario abordará que son las guías de práctica clínica en diabetes, cuáles son sus objetivos y su utilidad y se discutirán las dificultades en su elaboración y aplicación\n\n\n\n\n\nApr 10, 2024\n\n\nDr. Daniel Croatto\n\n\n\n\n\n\n\nPrediabetes\n\n\nEn este seminario hablamos sobre prediabetes desde un punto de vista individual y poblacional, y sobre las diferentes pruebas diagnósticas con las que se puede identificar. La discusión giró en torno a cuáles de estas pruebas son las más utilizadas en la práctica cotidiana y la transición a utilizar hemoglobina glucosilada como medida diagnóstica\n\n\n\n\n\nMar 6, 2024\n\n\nDaniel Witte\n\n\n\n\n\n\n\nCarga global de diabetes tipo 2. Prevalencia, incidencia y mortalidad\n\n\nEn este seminario se presentó al Steno Diabetes Center Aarhus, su estrategia de internacionalización de la investigación, y los seminarios en línea. El tema de la sesión fue la carga global de diabetes con un enfoque en prevalencia, sus componentes y su relación dinámica con incidencia y mortalidad.\n\n\n\n\n\nFeb 7, 2024\n\n\nDaniel Witte, Omar Silverman\n\n\n\n\n\nNo matching items"
  },
  {
    "objectID": "network.html",
    "href": "network.html",
    "title": "Quienes somos?",
    "section": "",
    "text": "La red SDCA-LATAM está conformada por colegas interesados(as) en la investigación en diabetes. Estos son algunos de los miembros de la red:\n\n\n\n\n\nDinamarca\n\n\n\n\n\n\n\n\nOmar Silverman\n\n\n\n\nOmar Silverman es postdoc en el Steno Diabetes Center Aarhus (SDCA) y la Universidad de Aarhus (AU) en Dinamarca. Le interesa la investigación en epidemiología de la diabetes con un énfasis en relaciones familiares. Es co-lider del proyecto de internacionalización de la investigación en el SDCA\n\n\n\n\nDaniel Witte es profesor de Epidemiología de la diabetes en AU y en el SDCA, Dinamarca. Le interesa la investigación en prevención y predicción de diabetes, así como de sus complicaciones. Daniel es co-lider del proyecto de internacionalización de la investigación en el SDCA\n\n\n\n\n\nDaniel Witte\n\n\n\n\n\n\n\n\n\nAnnelli Sandbaek\n\n\n\n\nAnnelli Sandbaek es profesora de medicina general en AU. Es Jefa de la Unidad de Colaboración Intersectorial y Atención Integrada de pacientes en el SDCA. Le interesa investigar cómo los sistemas de salud pueden brindar una mejor atencion a las personas que viven con enfermedades crónicas. Annelli es co-lider del proyecto de internacionalización de la investigación en el SDCA\n\n\n\n\n\n\nMéxico\n\n\n\n\n\n\n\n\nJosé Luis Flores Guerrero\n\n\n\n\nJosé Luis Flores es investigador en la Benemérita Universidad Autónoma de Puebla, Puebla, Mexico. Sus intereses se centran en la investigación interdisciplinaria sobre diabetes y enfermedades cardiometabólicas, integrando epidemiología y ciencia de datos, en particular el uso de R con fines de reproducibilidad\n\n\n\n\nMaría Zavala es coordinadora de investigación en ciencias de la salud en la Universidad Autónoma de Guadalajara, Ciencias de la Salud, Guadalajara, Jalisco, México. Su investigación se centra en la afectación del sistema inmune en enfermedades crónico degenerativas, autoinmunidad y enfermedades infecciosas\n\n\n\n\n\nMaría G. Zavala Cerna\n\n\n\n\n\n\n\n\n\nCecilia G. Acero Vidal\n\n\n\n\nCecilia Acero es postdoc en el Centro de Investigaciones y Estudios Superiores en Antropología Social (CIESAS) Sede Sureste (Chiapas). Su investigación está centrada en las experiencias de personas que viven con diabetes tipo 2 en contextos de alta desigualdad social, étnica y territorial en el sur de México\n\n\n\n\n\n\nColombia\n\n\n\n\n\n\n\n\nPaula Díaz\n\n\n\n\nPaula Díaz es Profesora Asociada en la Facultad Nacional de Salud Pública de la Universidad de Antioquia, en Colombia y la actual presidente de la Red de las Américas para la Vigilancia de Enfermedades Crónicas. Su labor investigativa se centra en la epidemiología de la diabetes, el monitoreo y la prevención de enfermedades crónicas, la planificación y educación para la salud.\n\n\n\n\nJuan Pablo Pérez es estudiante de doctorado en epidemiología en la Universidad de Antioquia, Medellín, Colombia. Le interesa la investigación relacionada con el perfil epidemiológico y los determinantes exposómicos en diabetes tipo 1.\n\n\n\n\n\nJuan Pablo Pérez Bedoya\n\n\n\n\n\n\n\n\n\nGabriel J. Matta Herrera\n\n\n\n\nGabriel Matta es médico internista con maestría en diabetes y obesidad. Es investigador independiente interesado en epidemiología. Actualmente trabaja con una cohorte de pacientes en Antioquia (Colombia) en la cuál le interesa describir las características sociodemográficas de los participantes, el pérfil de riesgo cardiovascular y su adherencia a guías clínicas\n\n\n\n\nBrenda Villalobos es médico internista y cardiologa intensivista. Es investigadora independiente interesada en realizar investigación clínica. Uno de sus principales intereses es el manejo integral de la prediabetes y su estrecha relación con la obesidad, así como el desarrollo de protocolos de atención para pacientes con un enfoque personalizado\n\n\n\n\n\nBrenda Villalobos Renteria\n\n\n\n\n\n\n\n\nPerú\n\n\n\n\n\n\n\n\nHarold Lizardo Torres Aparcana\n\n\n\n\nLizardo Torres es médico endocrinólogo en la Clínica San Felipe, Lima, Perú. Tiene una maestría en epidemiología y está interesado en la investigación sobre prevención de la diabetes tipo 2 y sus complicaciones cardio-reno-metabólicas\n\n\n\n\n\n\nArgentina\n\n\n\n\n\n\n\n\nDaniela Bensusan Martínez\n\n\n\n\nDaniela Bensusan es médica general e investigadora independiente. Sus intereses de investigación se relacionan con la estrimación de la carga de diabetes en la comunidad, retinopatía diabética, así como el manejo metabólico y de complicaciones de diabetes 2 en el primer nivel de atención\n\n\n\n\n\n\nEstados Unidos de América\n\n\n\n\n\n\n\n\nNoël C. Barengo\n\n\n\n\nNoël Barengo es profesor asociado en la Facultad de Medicina Herbert Wertheim de la Universidad Internacional de Florida en Estados Unidos. Sus intereses de investigación son la detección, prevención y control de la diabetes y el rol de la actividad física en la prevención de las enfermedades no transmisibles"
  },
  {
    "objectID": "seminars/2024-05-22.html",
    "href": "seminars/2024-05-22.html",
    "title": "Epidemiología de diabetes tipo 1/ Registro nacional de pacientes con diabetes tipo 1- RENACED-DT1",
    "section": "",
    "text": "presentación\nAccede a la grabación del seminario aquí"
  },
  {
    "objectID": "seminars/2024-04-10.html",
    "href": "seminars/2024-04-10.html",
    "title": "Guías de Práctica Clínica en Diabetes",
    "section": "",
    "text": "presentación\nAccede a la grabación del seminario aquí"
  },
  {
    "objectID": "seminars/2024-06-26.html",
    "href": "seminars/2024-06-26.html",
    "title": "Diabetes tipo 2 de inicio temprano en México",
    "section": "",
    "text": "Presentación/slides\nAccede a la grabación del seminario aquí/access the recording of the seminar here:"
  },
  {
    "objectID": "seminars/2024-02-07.html",
    "href": "seminars/2024-02-07.html",
    "title": "Carga global de diabetes tipo 2. Prevalencia, incidencia y mortalidad",
    "section": "",
    "text": "presentación"
  },
  {
    "objectID": "seminars/2024-08-14.html",
    "href": "seminars/2024-08-14.html",
    "title": "Epidemiología de las complicaciones y mortalidad por diabetes mellitus tipo 2: datos de Latino-América",
    "section": "",
    "text": "Presentación/slides\nAccede a la grabación del seminario aquí/access the recording of the seminar here:"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Proyecto de internacionalización",
    "section": "",
    "text": "Este proyecto tiene el objetivo de crear y expandir redes de colaboración entre investigadores del Centro Steno Aarhus de Diabetes (SDCA) con investigadores(as) de instituciones en la región de América Latina. Mediante una estrategia bottom-up, el proyecto de internacionalización promueve el intercambio de conocimiento mediante actividades educativas y de investigación que puedan contribuir al avance en la agenda de investigación en diabetes en la región de América Latina."
  },
  {
    "objectID": "calendar/2025-06-18.html",
    "href": "calendar/2025-06-18.html",
    "title": "Comprendiendo la complejidad en la Salud Pública con inteligencia artificial y registros poblacionales",
    "section": "",
    "text": "Presentación/slides\nAccede a la grabación/access the recording here"
  },
  {
    "objectID": "calendar/2025-09-24.html",
    "href": "calendar/2025-09-24.html",
    "title": "Puntajes z- IMC y debut de diabetes tipo 1 en niños",
    "section": "",
    "text": "Presentación/slides\nAccede a la grabación/access the recording here"
  },
  {
    "objectID": "calendar/2025-02-26.html",
    "href": "calendar/2025-02-26.html",
    "title": "Efectividad de la telemedicina en la prevención de diabetes tipo 2",
    "section": "",
    "text": "Presentación/slides\nAccede a la grabación del seminario aquí /Access the seminar recording here"
  },
  {
    "objectID": "calendar/2025-03-19.html",
    "href": "calendar/2025-03-19.html",
    "title": "Presentaciones cortas de los miembros de la red",
    "section": "",
    "text": "Presentación/slides\nAccede a la grabación del seminario aquí /Access the seminar recording here"
  },
  {
    "objectID": "calendar/2025-08-27.html",
    "href": "calendar/2025-08-27.html",
    "title": "Co-creación en investigación en diabetes: algunos ejemplos de Perú",
    "section": "",
    "text": "Presentación/slides\nAccede a la grabación/access the recording here"
  },
  {
    "objectID": "calendar/2025-04-23.html",
    "href": "calendar/2025-04-23.html",
    "title": "Determinantes sociales de la salud y prevención de la diabetes",
    "section": "",
    "text": "Presentación/slides\nAccede a la grabación del seminario aquí/Access the seminar recording here"
  },
  {
    "objectID": "calendar/2025-01-22.html",
    "href": "calendar/2025-01-22.html",
    "title": "Utilidad de las nuevas clasificaciones de Diabetes",
    "section": "",
    "text": "Presentación/ slides\nAccede a la grabación del seminario aquí/access the seminar recording here"
  },
  {
    "objectID": "calendar/2025-11-19.html",
    "href": "calendar/2025-11-19.html",
    "title": "Aspectos emocionales en pacientes con diabetes mellitus",
    "section": "",
    "text": "Publicidad/advertisement\nRegistrate aquí/register here"
  },
  {
    "objectID": "calendar/2025-10-22.html",
    "href": "calendar/2025-10-22.html",
    "title": "Puede América Latina implementar un programa de remisión de diabetes a nivel regional?",
    "section": "",
    "text": "Publicidad/advertisement\nRegistrate aqui/register here"
  },
  {
    "objectID": "calendar/2025-05-21.html",
    "href": "calendar/2025-05-21.html",
    "title": "Carga de las enfermedades metabólicas: perspectivas desde América Latina",
    "section": "",
    "text": "Presentación/slides\nAccede a la grabación/access the recording here"
  },
  {
    "objectID": "LICENSE.html",
    "href": "LICENSE.html",
    "title": "Proyecto de internacionalización",
    "section": "",
    "text": "Attribution 4.0 International\n=======================================================================\nCreative Commons Corporation (“Creative Commons”) is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an “as-is” basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.\nUsing Creative Commons Public Licenses\nCreative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.\n Considerations for licensors: Our public licenses are\n intended for use by those authorized to give the public\n permission to use material in ways otherwise restricted by\n copyright and certain other rights. Our licenses are\n irrevocable. Licensors should read and understand the terms\n and conditions of the license they choose before applying it.\n Licensors should also secure all rights necessary before\n applying our licenses so that the public can reuse the\n material as expected. Licensors should clearly mark any\n material not subject to the license. This includes other CC-\n licensed material, or material used under an exception or\n limitation to copyright. More considerations for licensors:\nwiki.creativecommons.org/Considerations_for_licensors\n\n Considerations for the public: By using one of our public\n licenses, a licensor grants the public permission to use the\n licensed material under specified terms and conditions. If\n the licensor's permission is not necessary for any reason--for\n example, because of any applicable exception or limitation to\n copyright--then that use is not regulated by the license. Our\n licenses grant only permissions under copyright and certain\n other rights that a licensor has authority to grant. Use of\n the licensed material may still be restricted for other\n reasons, including because others have copyright or other\n rights in the material. A licensor may make special requests,\n such as asking that all changes be marked or described.\n Although not required by our licenses, you are encouraged to\n respect those requests where reasonable. More considerations\n for the public: \nwiki.creativecommons.org/Considerations_for_licensees\n=======================================================================\nCreative Commons Attribution 4.0 International Public License\nBy exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution 4.0 International Public License (“Public License”). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.\nSection 1 – Definitions.\n\nAdapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.\nAdapter’s License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.\nCopyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.\nEffective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.\nExceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.\nLicensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.\nLicensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.\nLicensor means the individual(s) or entity(ies) granting rights under this Public License.\nShare means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.\nSui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.\nYou means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.\n\nSection 2 – Scope.\n\nLicense grant.\n\nSubject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:\n\nreproduce and Share the Licensed Material, in whole or in part; and\nproduce, reproduce, and Share Adapted Material.\n\nExceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.\nTerm. The term of this Public License is specified in Section 6(a).\nMedia and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a)\n\nnever produces Adapted Material.\n\nDownstream recipients.\n\nOffer from the Licensor – Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.\nNo downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.\n\nNo endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).\n\nOther rights.\n\nMoral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.\nPatent and trademark rights are not licensed under this Public License.\nTo the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties.\n\n\nSection 3 – License Conditions.\nYour exercise of the Licensed Rights is expressly made subject to the following conditions.\n\nAttribution.\n\nIf You Share the Licensed Material (including in modified form), You must:\n\nretain the following if it is supplied by the Licensor with the Licensed Material:\n\nidentification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);\na copyright notice;\na notice that refers to this Public License;\na notice that refers to the disclaimer of warranties;\na URI or hyperlink to the Licensed Material to the extent reasonably practicable;\n\nindicate if You modified the Licensed Material and retain an indication of any previous modifications; and\nindicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.\n\nYou may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.\nIf requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.\nIf You Share Adapted Material You produce, the Adapter’s License You apply must not prevent recipients of the Adapted Material from complying with this Public License.\n\n\nSection 4 – Sui Generis Database Rights.\nWhere the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:\n\nfor the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database;\nif You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and\nYou must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.\n\nFor the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.\nSection 5 – Disclaimer of Warranties and Limitation of Liability.\n\nUNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.\nTO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.\nThe disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.\n\nSection 6 – Term and Termination.\n\nThis Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.\nWhere Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:\n\nautomatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or\nupon express reinstatement by the Licensor.\n\nFor the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.\nFor the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.\nSections 1, 5, 6, 7, and 8 survive termination of this Public License.\n\nSection 7 – Other Terms and Conditions.\n\nThe Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.\nAny arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.\n\nSection 8 – Interpretation.\n\nFor the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.\nTo the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.\nNo term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.\nNothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.\n\n=======================================================================\nCreative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark “Creative Commons” or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.\nCreative Commons may be contacted at creativecommons.org."
  },
  {
    "objectID": "directory.html",
    "href": "directory.html",
    "title": "Website Directory",
    "section": "",
    "text": "These are other websites across Steno Aarhus:\n\nOfficial site: The official Region Midt website for more general public information and details.\nResearch Common Docs: Common documents and operating prodecures for researchers across Steno Aarhus.\nEpidemiology and Statistics: Events and activities related to epidemiology and statistics.\nRegister Research Space: Events and activities related to register-based research.\nInternationalization: Efforts to spread knowledge and connect with other countries, specifically Latin America.\nEpidemiology Group: Documentation for meetings within the epidemiology group.\nCoding Cafe: Schedule for in-person coding support and help."
  },
  {
    "objectID": "seminars/2024-12-11.html",
    "href": "seminars/2024-12-11.html",
    "title": "Incidencia de diabetes tipo 1 y su relación con la carga genética",
    "section": "",
    "text": "Presentación/slides\nAccede a la grabación del seminario aquí/access the seminar recording here"
  },
  {
    "objectID": "seminars/2024-10-23.html",
    "href": "seminars/2024-10-23.html",
    "title": "Utilidad de la glicemia 1h-post carga en la caracterización de sujetos con Prediabetes",
    "section": "",
    "text": "Presentación/slides\nAccede a la grabación del seminario aqui/Access the recording of the seminar here:"
  },
  {
    "objectID": "seminars/2024-09-18.html",
    "href": "seminars/2024-09-18.html",
    "title": "Presentaciones cortas de los miembros de la red",
    "section": "",
    "text": "Presentación/slides\nAccede a la grabación del seminario aqui/Access the recording of the seminar here:"
  },
  {
    "objectID": "seminars/2024-03-06.html",
    "href": "seminars/2024-03-06.html",
    "title": "Prediabetes",
    "section": "",
    "text": "presentación\nAccede a la grabación del seminario aquí"
  },
  {
    "objectID": "seminars/2024-11-20.html",
    "href": "seminars/2024-11-20.html",
    "title": "Estudios de cohorte digitales",
    "section": "",
    "text": "Presentación/slides"
  },
  {
    "objectID": "calendar.html",
    "href": "calendar.html",
    "title": "Calendario seminarios 2025",
    "section": "",
    "text": "SDCA lleva a cabo una serie de seminarios en línea sobre investigación en diabetes cómo parte de su estrategia de internacionalización hacia la región de América Latina. Los objetivos de estos seminarios son el intercambio de conocimiento con un enfoque en la investigación en diabetes que se realiza en los diferentes grupos y contextos, conocer sus intereses de investigación e identificar potenciales colaboradores.\n\n\n\n\n\n\n\n\n\nUtilidad de las nuevas clasificaciones de Diabetes\n\n\n\n\n\n\n\n\nJan 22, 2025\n\n\nDr. Gabriel Matta\n\n\n\n\n\n\n\nEfectividad de la telemedicina en la prevención de diabetes tipo 2\n\n\n\n\n\n\n\n\nFeb 26, 2025\n\n\nDr. Harold Lizardo Torres Aparcana\n\n\n\n\n\n\n\nPresentaciones cortas de los miembros de la red\n\n\n\n\n\n\n\n\nMar 19, 2025\n\n\nMiembros de la red\n\n\n\n\n\n\n\nDeterminantes sociales de la salud y prevención de la diabetes\n\n\n\n\n\n\n\n\nApr 23, 2025\n\n\nDr. Noël C. Barengo\n\n\n\n\n\n\n\nCarga de las enfermedades metabólicas: perspectivas desde América Latina\n\n\n\n\n\n\n\n\nMay 21, 2025\n\n\nDr. Carlos Toro Huamanchumo\n\n\n\n\n\n\n\nComprendiendo la complejidad en la Salud Pública con inteligencia artificial y registros poblacionales\n\n\n\n\n\n\n\n\nJun 18, 2025\n\n\nProfesor asistente Adrian G. Zucco\n\n\n\n\n\n\n\nCo-creación en investigación en diabetes: algunos ejemplos de Perú\n\n\n\n\n\n\n\n\nAug 27, 2025\n\n\nPhD Jessica Zafra\n\n\n\n\n\n\n\nPuntajes z- IMC y debut de diabetes tipo 1 en niños\n\n\n\n\n\n\n\n\nSep 24, 2025\n\n\nDra. Valeria Hirschler\n\n\n\n\n\n\n\nPuede América Latina implementar un programa de remisión de diabetes a nivel regional?\n\n\n\n\n\n\n\n\nOct 22, 2025\n\n\nDr. Victor Villalobos\n\n\n\n\n\n\n\nAspectos emocionales en pacientes con diabetes mellitus\n\n\n\n\n\n\n\n\nNov 19, 2025\n\n\nDra. Adriana Alvarez\n\n\n\n\n\n\n\nTBA\n\n\n\n\n\n\n\n\nDec 17, 2025\n\n\nTBC\n\n\n\n\n\nNo matching items"
  }
]